Modified Patient Stem Cells as Prelude to Autologous Treatment of Muscular Dystrophy

K.E. Davies; Miranda Grounds

doi:10.1016/j.stem.2007.11.003

Modified Patient Stem Cells as Prelude to Autologous Treatment of Muscular Dystrophy

K.E. Davies, Miranda Grounds

Research output: Contribution to journal › Letter

5 Citations (Scopus)

Abstract

Duchenne muscular dystrophy is a devastating muscle wasting disease for which there is no effective treatment. In this issue of Cell Stem Cell, Benchaouir et al. (2007) demonstrate the delivery of genetically corrected CD133+ patient cells into mice, suggesting a new potential avenue for autologous cell therapy.

Original language	English
Pages (from-to)	595-560
Journal	Cell Stem Cell
Volume	1
Issue number	6
DOIs	https://doi.org/10.1016/j.stem.2007.11.003
Publication status	Published - 2007

Access to Document

10.1016/j.stem.2007.11.003

Cite this

@article{0cb8184a2f534b0aab499c1132497b03,

title = "Modified Patient Stem Cells as Prelude to Autologous Treatment of Muscular Dystrophy",

abstract = "Duchenne muscular dystrophy is a devastating muscle wasting disease for which there is no effective treatment. In this issue of Cell Stem Cell, Benchaouir et al. (2007) demonstrate the delivery of genetically corrected CD133+ patient cells into mice, suggesting a new potential avenue for autologous cell therapy.",

author = "K.E. Davies and Miranda Grounds",

year = "2007",

doi = "10.1016/j.stem.2007.11.003",

language = "English",

volume = "1",

pages = "595--560",

journal = "Cell Stem Cell",

issn = "1934-5909",

publisher = "CPS/Elsevier",

number = "6",

}

TY - JOUR

T1 - Modified Patient Stem Cells as Prelude to Autologous Treatment of Muscular Dystrophy

AU - Davies, K.E.

AU - Grounds, Miranda

PY - 2007

Y1 - 2007

N2 - Duchenne muscular dystrophy is a devastating muscle wasting disease for which there is no effective treatment. In this issue of Cell Stem Cell, Benchaouir et al. (2007) demonstrate the delivery of genetically corrected CD133+ patient cells into mice, suggesting a new potential avenue for autologous cell therapy.

AB - Duchenne muscular dystrophy is a devastating muscle wasting disease for which there is no effective treatment. In this issue of Cell Stem Cell, Benchaouir et al. (2007) demonstrate the delivery of genetically corrected CD133+ patient cells into mice, suggesting a new potential avenue for autologous cell therapy.

U2 - 10.1016/j.stem.2007.11.003

DO - 10.1016/j.stem.2007.11.003

M3 - Letter

C2 - 18371397

VL - 1

SP - 595

EP - 560

JO - Cell Stem Cell

JF - Cell Stem Cell

SN - 1934-5909

IS - 6

ER -

Modified Patient Stem Cells as Prelude to Autologous Treatment of Muscular Dystrophy

Abstract

Access to Document

Fingerprint

Cite this